When we looked at the relative levels of SDHC mRNA, we found no difference between the n = 204 cohort tumors classified as either ER+ and ER−, or as ductal and lobular carcinoma (Fig. 2a). The gene discussed is SDHC; the disease is breast lobular carcinoma.